BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18958837)

  • 1. Insulin therapy in acute coronary syndromes: an appraisal of completed and ongoing randomised trials with important clinical end points.
    Goyal A; Nerenberg K; Gerstein HC; Umpierrez G; Wilson PW
    Diab Vasc Dis Res; 2008 Nov; 5(4):276-84. PubMed ID: 18958837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycaemia and its therapy during acute coronary syndromes.
    Inzucchi SE
    Diab Vasc Dis Res; 2008 Nov; 5(4):259. PubMed ID: 18958834
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of blood glucose in patients with acute coronary syndromes.
    Lipska KJ; Kosiborod M
    Rev Cardiovasc Med; 2012; 13(2-3):e77-88. PubMed ID: 23160165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to 'Insulin therapy in acute coronary syndromes'.
    de Mulder M; Umans VA
    Diab Vasc Dis Res; 2009 Apr; 6(2):139. PubMed ID: 20368204
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglycaemia in acute coronary syndromes: risk-marker or therapeutic target?
    Anantharaman R; Heatley M; Weston CF
    Heart; 2009 May; 95(9):697-703. PubMed ID: 18697807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
    Selker HP; Beshansky JR; Sheehan PR; Massaro JM; Griffith JL; D'Agostino RB; Ruthazer R; Atkins JM; Sayah AJ; Levy MK; Richards ME; Aufderheide TP; Braude DA; Pirrallo RG; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Opie LH; Rackley CE; Apstein CS; Udelson JE
    JAMA; 2012 May; 307(18):1925-33. PubMed ID: 22452807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.
    Selker HP; Harris WS; Rackley CE; Marsh JB; Ruthazer R; Beshansky JR; Rashba EJ; Peter I; Opie LH
    Am Heart J; 2016 Aug; 178():168-75. PubMed ID: 27502865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute coronary syndrome revisited: effects and therapeutic modulation of excess metabolic fuel supply.
    Essop MF; Opie LH
    Cardiovasc J Afr; 2020; 31(3):159-161. PubMed ID: 32627801
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemia.
    Vivas D; García-Rubira JC; Bernardo E; Angiolillo DJ; Martín P; Calle A; Núñez-Gil I; Macaya C; Fernández-Ortiz A
    Rev Esp Cardiol (Engl Ed); 2014 Jan; 67(1):22-7. PubMed ID: 24774260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of glycemic control in the coronary care unit with recommendations for clinical management.
    Kosiborod M; Deedwania P
    J Diabetes Sci Technol; 2009 Nov; 3(6):1342-51. PubMed ID: 20144388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection by glucose-insulin-potassium in acute coronary syndrome patients undergoing urgent multivessel off-pump coronary artery bypass surgery.
    Shim JK; Yang SY; Yoo YC; Yoo KJ; Kwak YL
    Br J Anaesth; 2013 Jan; 110(1):47-53. PubMed ID: 22986417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.
    Selker HP; Beshansky JR; Griffith JL; D'Agostino RB; Massaro JM; Udelson JE; Rashba EJ; Ruthazer R; Sheehan PR; Desvigne-Nickens P; Rosenberg YD; Atkins JM; Sayah AJ; Aufderheide TP; Rackley CE; Opie LH; Lambrew CT; Cobb LA; Macleod BA; Ingwall JS; Zalenski RJ; Apstein CS
    Am Heart J; 2012 Mar; 163(3):315-22. PubMed ID: 22424000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.
    Pittas AG; Siegel RD; Lau J
    Arch Intern Med; 2004 Oct; 164(18):2005-11. PubMed ID: 15477435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial.
    de Mulder M; Umans VA; Cornel JH; van der Zant FM; Stam F; Oemrawsingh RM; Akkerhuis KM; Boersma E
    JAMA Intern Med; 2013 Nov; 173(20):1896-904. PubMed ID: 24018647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies.
    Angeli F; Reboldi G; Poltronieri C; Aita A; Bartolini C; Verdecchia P
    Mini Rev Med Chem; 2015; 15(14):1164-73. PubMed ID: 26202190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.
    Angeli F; Reboldi G; Poltronieri C; Lazzari L; Sordi M; Garofoli M; Bartolini C; Verdecchia P
    Ther Adv Cardiovasc Dis; 2015 Dec; 9(6):412-24. PubMed ID: 26194489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin therapy in critically ill patients.
    Solano T; Totaro R
    Curr Opin Clin Nutr Metab Care; 2004 Mar; 7(2):199-205. PubMed ID: 15075712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial.
    van der Horst IC; Zijlstra F; van 't Hof AW; Doggen CJ; de Boer MJ; Suryapranata H; Hoorntje JC; Dambrink JH; Gans RO; Bilo HJ;
    J Am Coll Cardiol; 2003 Sep; 42(5):784-91. PubMed ID: 12957421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change.
    Trence DL; Kelly JL; Hirsch IB
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2430-7. PubMed ID: 12788838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.